南方制药 (831207.OC)

+ 收藏

财务摘要(报告期)(南方制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.030.010.030.070.04
 每股收益 - 稀释(元) 0.030.010.030.070.04
 每股收益 - 期末股本摊薄(元) 0.030.010.030.060.03
 每股净资产BPS(元) 3.673.643.723.693.66
 每股经营活动产生的现金流量净额(元) -0.030.05-0.050.14-0.03
 每股营业收入(元) 0.410.860.400.850.40
关键比率:
 净资产收益率 - 摊薄(%) 0.850.390.821.740.81
 净资产收益率 - 加权(%) 0.860.390.831.931.17
 净资产收益率 - 平均(%) 0.860.390.832.140.99
 净资产收益率 - 扣除(%) 0.24-0.650.290.960.38
 总资产净利率 - 平均(%) 0.650.310.691.660.81
 总资产报酬率ROA(%) 0.800.610.801.860.96
 投入资本回报率ROIC(%) 0.820.560.821.980.93
 销售毛利率(%) 34.0531.2634.3534.9533.56
 销售净利率(%) 7.401.597.707.787.96
 资产负债率(%) 20.2220.5216.7815.8516.43
 资产周转率(倍) 0.090.190.090.210.10
 销售商品提供劳务收到的现金/营业收入(%) 90.0776.4891.1487.5188.52
 营业利润同比增长率(%) 1.71-75.06-13.89-12.189.01
 营业收入同比增长率(%) 4.173.19-1.3133.0835.27
 利润总额同比增长率(%) 1.66-73.59-12.7010.159.90
 归属母公司股东的净利润同比增长率(%) 3.97-77.423.8518.12-4.64
 扣非后归属母公司股东的净利润同比增长率(%) -15.44-168.44-23.56-32.427.20
 总资产同比增长率(%) 4.786.372.1724.7735.27
 总负债同比增长率(%) 26.2637.744.36-42.72-25.00
 净资产同比增长率(%) 0.470.481.7660.8560.96
利润表摘要:
 营业总收入(元) 78,423,044.23165,369,870.0075,280,652.89160,249,897.9576,282,807.53
 营业总成本(元) 77,207,309.97165,780,155.3073,298,354.44152,373,828.0972,820,264.10
 营业收入(元) 78,423,044.23165,369,870.0075,280,652.89160,249,897.9576,282,807.53
 营业利润(元) 6,123,281.273,483,247.386,020,617.5013,965,325.866,991,440.02
 利润总额(元) 6,133,289.553,404,256.956,033,349.8212,892,250.116,911,308.04
 净利润(元) 5,803,015.162,622,188.135,796,378.9012,459,847.996,073,861.17
 归属母公司股东的净利润(元) 6,016,478.732,729,334.515,786,597.4712,085,347.875,572,191.03
 非经常性损益(元) 4,314,654.557,304,331.763,773,957.365,400,829.022,939,206.02
 归属母公司股东的净利润扣除非经常性损益(元) 1,701,824.18-4,574,997.252,012,640.116,684,518.852,632,985.01
资产负债表摘要:
 流动资产(元) 321,990,374.70348,413,862.50353,556,374.30373,199,620.75414,565,888.01
 固定资产(元) 297,330,006.20291,391,961.75276,628,970.78277,368,548.8694,195,057.12
 长期股权投资(元) 36,096,970.2731,948,042.1315,943,833.569,625,457.9411,810,485.63
 资产总计(元) 889,464,907.32885,542,725.32848,848,215.49832,544,852.08830,854,268.85
 流动负债(元) 146,318,420.18145,258,727.66117,562,758.97105,428,773.37112,337,560.37
 非流动负债(元) 33,548,928.7136,486,972.7324,895,975.1026,522,976.1824,166,196.55
 负债合计(元) 179,867,348.89181,745,700.39142,458,734.07131,951,749.55136,503,756.92
 股东权益(元) 709,597,558.43703,797,024.93706,389,481.42700,593,102.53694,350,511.93
 归属母公司股东的权益(元) 705,123,827.55699,320,812.39701,796,341.08696,009,743.61689,639,982.99
 资本公积(元) 352,371,815.09352,371,815.09348,155,080.82348,155,080.82348,298,477.04
 盈余公积(元) 25,580,034.5225,580,034.5224,966,069.6824,966,069.6823,724,385.55
 未分配利润(元) 142,306,977.94136,503,962.78140,175,190.58134,388,593.11129,117,120.40
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 70,638,163.57126,471,973.3568,609,686.63140,239,266.4867,522,940.73
 经营活动产生的现金净流量(元) -6,323,561.719,711,130.64-8,537,762.3327,154,160.33-5,105,394.92
 购建固定无形长期资产支付的现金(元) 36,359,453.8490,053,498.2538,195,863.85106,591,305.1740,509,630.47
 投资支付的现金(元) 21,950,000.00165,400,000.00111,900,000.00349,464,640.006,927,098.64
 投资活动产生的现金净流量(元) -23,213,190.35-94,056,882.21-58,871,028.22-148,364,492.38-47,436,729.11
 吸收投资收到的现金(元) -7,270,000.00-251,210,566.05251,600,000.00
 取得借款收到的现金(元) 72,760,000.00158,645,150.0084,820,000.0085,003,034.0066,834,050.00
 筹资活动产生的现金净流量(元) -2,518,720.2249,551,024.0916,980,918.62150,363,247.74158,671,573.02
 现金及现金等价物净增加(元) -31,560,335.34-34,329,597.77-50,127,658.6329,689,981.71106,338,600.49
 期末现金及现金等价物余额(元) 14,431,412.7938,179,921.6827,259,533.5472,509,519.45149,158,138.23
 折旧与摊销(元) 15,606,050.2939,502,886.4015,567,957.5526,365,660.898,264,011.39
公告日期 2024-08-292024-04-232023-08-302023-03-312022-08-31
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院